Ureter Urothelial Carcinoma
3 clinical trials · Condition
◉ Watch Ureter Urothelial Carcinoma
| Record | Firm | Date |
|---|---|---|
| Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery (NCT02812420) | M.D. Anderson Cancer Center | 2017-03-07 |
| Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors (NCT02496208) | National Cancer Institute (NCI) | 2015-07-22 |
| Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery (NCT02178241) | National Cancer Institute (NCI) | 2014-12-11 |
Track Ureter Urothelial Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.